ScienceDex / Researcher record
Zieler, Helge
- Primrose Bio, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
- Rising Star
- Early Career
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2018 | $224,963 | 1 | #32,079 |
| 2021 | $521,286 | 2 | #20,982 |
| 2022 | $1,059,968 | 1 | #9,102 |
| 2023 | $983,775 | 1 | #10,456 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20181 record
- FY20212 records
- FY20221 record
- FY2023 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2018 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2023 award records by amount
NIH award records listing Zieler, Helge as a PI. Multi-PI records show the full award amount for context.
- 5R44HG010995-03R44Contact PIDNA 3.0: Development of a novel, efficient and cost-effective enzymatic process for synthesis of DNA oligonucleotides$983.8Kaward amount
Award organization
Organizations that administered FY2023 awards listing Zieler, Helge as a PI.
FY2023 award administered by Primrose Bio, Inc. (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2018First NIH AwardPrimrose Bio, Inc.
- 2021$500K Cumulative Funding
- 2022$1M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #9102
- 2023$2M Cumulative Funding